Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 89   

Articles published

ARNA 1.67 -0.01 (-0.60%)
price chart
Biotech stocks for your portfolio: Inovio Pharmaceuticals, Inc. (INO), Arena ...
Inovio Pharmaceuticals, Inc. (INO) ended last trading session with a change of -3.08 percent. It trades at an average volume of 1.64M shares versus 1.07M shares recorded at the end of last trading session.
Biotech Stocks Worth Chasing: Arena Pharmaceuticals, Inc. (ARNA), ZIOPHARM ...
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of 2.41 percent. It trades at an average volume of 1.75M shares versus 1.84M shares recorded at the end of last trading session.
Which way Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) insiders are heading
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) up 11.25 per cent in the past week, is under coverage of 7 analysts who collectively recommend a hold rating on stock.
Broker Outlook For Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)  Fiscal Standard
Active Biotech Stock News: Halozyme Therapeutics, Inc. (HALO), Arena ...
Arena Pharmaceuticals, Inc. (ARNA) recently recorded 0 percent change and currently at $1.78 is 36.92 percent away from its 52-week low and down -59.36 percent versus its peak.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Updated Price Targets
05/13/2015 - Arena Pharmaceuticals, Inc. had its “market perform” rating reiterated by analysts at BMO Capital Markets.
Latest Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Target Price Suggests Stock ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) up 1.2 per cent in the past week, is under coverage of 7 analysts who collectively recommend a hold rating on stock.
Two Stocks within Analysts Review: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...  Street Updates
Trading the Biotech News: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Biogen ...  The Voice Registrar
Arena Pharmaceuticals Inc. (ARNA) Shares Bought by Wellington Management Group LLP
Arena Pharmaceuticals logo Wellington Management Group LLP raised its position in shares of Arena Pharmaceuticals Inc. (NASDAQ:ARNA) by 7.0% during the first quarter, according to its most recent Form 13F filing with the Securities and Exchange ...
How Analysts Feel About Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)?  Press Telegraph
Biotech Companies To Look Out For: Arena Pharmaceuticals, Inc. (ARNA), Celldex ...
Arena Pharmaceuticals, Inc. (ARNA) ended last trading session with a change of 1.87 percent. It trades at an average volume of 1.74M shares versus 2.09M shares recorded at the end of last trading session.
Analyst Rating Trends to Observe: Medtronic plc (NYSE:MDT) , Arena ...  Street Updates
Hot Biotech Stocks Recap: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...  The Voice Registrar
Biotech Stocks Worth a Closer Look: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) climbed 2.4% by the end of recent close at $1.71. For the ongoing quarter, the 6 Wall Street analysts providing adjusted earnings per share outlook have a consensus estimate of -$0.1/share, which would ...
Hot Biotech Stocks To Watch Right Now: Celldex Therapeutics, Inc. (CLDX ...
Arena Pharmaceuticals, Inc. (ARNA) recently recorded 2.4 percent change and currently at $1.71 is 31.54 percent away from its 52-week low and down -58.99 percent versus its peak.